TCEA1P2

Across TCGA pan-cancer cohorts, TCEA1P2 RNA is linked to patient survival in 26 of 34 cancer types, making it the most broadly survival-associated TCEA1P2 data layer.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher TCEA1P2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated TCEA1P2 expression acts as an unfavorable survival marker, although some lineages such as UCS and KIRC show a favorable association.

CESC, UVM, and STAD are the cancer types where TCEA1P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	DFS	Quartile	All	0.432	0.764	<.001	48	view →
UVM	DFS	Quartile	All	0.255	0.792	.002	44	view →
STAD	DFS	Median	IV	0.128	0.667	.005	42	view →
UCS	DFS	Median	IV	0.952	0.367	.001	42	view →
KIRC	DFS	Median	All	0.853	0.739	.010	34	view →
SKCM	DFS	Quartile	All	0.260	0.161	.005	25	view →
BLCA	DFS	Median	II,III,IV	0.447	0.564	.006	16	view →
SARC	OS	Quartile	All	0.420	0.711	.002	16	view →
LUAD	OS	Tertile	All	0.244	0.513	.001	15	view →
PAAD	OS	Quartile	All	0.340	0.600	.019	12	view →
BRCA	DFS	Quartile	III,IV	0.709	0.372	.008	12	view →
LUSC	DFS	Quartile	III,IV	0.467	0.822	.003	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 26 lineages.

TCEA1P2–CESC (DFS)

Open the CESC breakdown →